Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-131X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues ; volume:35 ; number:12 ; day:3 ; month:10 ; year:2018 ; pages:1-6 ; date:12.2018
Medical oncology ; 35, Heft 12 (3.10.2018), 1-6, 12.2018
- Creator
-
Tantiwetrueangdet, Anchalee
- Contributor
-
Panvichian, Ravat
Wongwaisayawan, Sansanee
Sueangoen, Natthaporn
Lertsithichai, Panuwat
SpringerLink (Online service)
- DOI
-
10.1007/s12032-018-1210-8
- URN
-
urn:nbn:de:101:1-2018111221050874111542
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tantiwetrueangdet, Anchalee
- Panvichian, Ravat
- Wongwaisayawan, Sansanee
- Sueangoen, Natthaporn
- Lertsithichai, Panuwat
- SpringerLink (Online service)
Other Objects (12)
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Is HER2 amplification predictable by digital immunohistochemistry?
HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method
Correction to: HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method
Amplification of HER2 is a marker for global genomic instability
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases
HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results
KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma
Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Is HER2 amplification predictable by digital immunohistochemistry?
HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method
Correction to: HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method
Amplification of HER2 is a marker for global genomic instability
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases
HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results
KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma
Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Is HER2 amplification predictable by digital immunohistochemistry?
HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method
Correction to: HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method
Amplification of HER2 is a marker for global genomic instability
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases
HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results
KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma